Stockhub

Moberg Pharma AB: Revision history

View logs for this page

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

14 August 2022

13 August 2022

9 August 2022

  • curprev 11:2811:28, 9 August 2022‎ 109.180.50.163 talk‎ 453 bytes +453‎ Created page with "Moberg Pharma AB (publ), a pharmaceutical company, develops and commercializes medical products in Europe, the United States, and internationally. It develops MOB-015, which has completed Phase III clinical trial for the treatment of nail fungus. The company was formerly known as Moberg Derma AB (publ) and changed its name to Moberg Pharma AB (publ) in May 2013. Moberg Pharma AB (publ) was incorporated in 2006 and is headquartered in Bromma, Sweden." Tag: Visual edit
Retrieved from ‘https://stockhub.co/research/Moberg_Pharma_AB’